Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO)

Fahad Abdullah Al Wadani; Khalid Mohammad Alabdulwahhab

doi:10.5455/mjhs.2019.01.008

2025, Vol: 13, Issue: 2

13 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

MANUSCRIPT CHECKLIST_(v2r)_
Title Page

« Previous Article

Original Research
Online Published: 10 Feb 2019

Majmaah J Heal Sci. 2019; 7(1): 77-85

doi: 10.5455/mjhs.2019.01.008

Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO)

Fahad Abdullah Al Wadani, Khalid Mohammad Alabdulwahhab.

Abstract
Background: Optical Coherence Tomography (OCT) has been used to evaluate the impact of Anti VEGF agents in cases of macular edema due to retinal vein occlusion. This study is to associate the visual outcomes to the type of edema, reflectivity and macular thickness on OCT.

Method: Patients who were to undergo intravitreal bevacizumab (IVB) injection for treating macular edema secondary to non-ischemic branch retinal venous occlusion (BRVO) were included in our study. The OCT findings were analyzed to assess the visual potential in these eyes. This cohort study was undertaken in 18-2016. Medical retina specialist examined all eyes. Best corrected visual acuity (BCVA), status of anterior and posterior segment of eyes were noted. OCT findings focused on type of edema, central retinal thickness (CRT) and reflectivity of fluid in front and within retinal layers. Macular edema was treated with IVB. On 1st follow up (6-4 weeks), BCVA, reduction in central retinal thickness and absorption of retinal fluid were noted.

Results: Our cohort had 61 eyes of 60 patients. In 32 eyes with Cystoid macular edema (CME), vision improved with an average of two lines or more. In 14 eyes with sub-retinal fluid vision was stable on 1st follow up. In 35 eyes with good reflectivity (pretreatment OCT), visual improvement was significant compared to those 26 eyes with poor reflectivity. The mean CRT declined from 373 micron to 215.5 micron. However, it was not associated with improvement of visual acuity on follow up. None of the eyes had increased intraocular pressure on first follow up.

Conclusion: OCT can guide to the prognostic outcome of patients with macular edema secondary to venous occlusion to be treated with IVB in non-ischemic branch venous occlusion.

Key words: Retinal vein occlusion, Macular edema, Intravitreal bevacizumab injection, Vision

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Fahad Abdullah Al Wadani Articles by Khalid Mohammad Alabdulwahhab
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Wadani FAA, Alabdulwahhab KM. Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). Majmaah J Heal Sci. 2019; 7(1): 77-85. doi:10.5455/mjhs.2019.01.008

Web Style

Wadani FAA, Alabdulwahhab KM. Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). https://www.mjhs-mu.org/?mno=302644051 [Access: September 12, 2024]. doi:10.5455/mjhs.2019.01.008

AMA (American Medical Association) Style

Wadani FAA, Alabdulwahhab KM. Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). Majmaah J Heal Sci. 2019; 7(1): 77-85. doi:10.5455/mjhs.2019.01.008

Vancouver/ICMJE Style

Wadani FAA, Alabdulwahhab KM. Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). Majmaah J Heal Sci. (2019), [cited September 12, 2024]; 7(1): 77-85. doi:10.5455/mjhs.2019.01.008

Harvard Style

Wadani, F. A. A. & Alabdulwahhab, . K. M. (2019) Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). Majmaah J Heal Sci, 7 (1), 77-85. doi:10.5455/mjhs.2019.01.008

Turabian Style

Wadani, Fahad Abdullah Al, and Khalid Mohammad Alabdulwahhab. 2019. Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). Majmaah Journal of Health Sciences, 7 (1), 77-85. doi:10.5455/mjhs.2019.01.008

Chicago Style

Wadani, Fahad Abdullah Al, and Khalid Mohammad Alabdulwahhab. "Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO)." Majmaah Journal of Health Sciences 7 (2019), 77-85. doi:10.5455/mjhs.2019.01.008

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Wadani, F. A. A. & Alabdulwahhab, . K. M. (2019) Optical Coherent Tomography (OCT) Helps In Predicting Visual Outcomes Of Eyes Treated With Intravitreal Bevacizumab For Macular Edema Due To Non-Ischemic Branch Retinal Vein Occlusion (BRVO). Majmaah Journal of Health Sciences, 7 (1), 77-85. doi:10.5455/mjhs.2019.01.008

About Majmaah Journal of Health Sciences

Contact Information

How to cite this article